http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-674930-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-16 |
| filingDate | 1988-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3e8d17d571f2deb273a175575be8e6f |
| publicationDate | 1990-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CH-674930-A5 |
| abstract | Topical compositions for the treatment of acne, comprise at least one puridone derivative: <IMAGE> in which: R1 is H, C1-17 alkyl, C5-8 cycloalkyl, cycloalkylalkylene group, the alkylene group having from 1 to 4 carbon atoms, aryl, aralkyl, the alkyl group having from 1 to 4 carbon atoms, arylalkenyl, the alkenyl group having from 2 to 4 carbon atoms, the aryl and cycloalkyl groups optionally substituted with C1-4 alkyl or alkoxy; R2 is H, C1-4 alkyl, C2-4 alkenyl, halogen atom or benzyl; R3 is H, C1-4 alkyl or phenyl; and R4 is H, C1-4 alkyl, C2-4 alkenyl, methoxymethyl, halogen or benzyl; as well as their cosmetically or pharmaceutically acceptable salts, and at least one antibacterial agent chosen from macrolide antibiotics and pyranosides, as well as their salts or esters. Preferred compositions contain octopirox or cyclopirox and erythromycin or clindamycin. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008035152-A1 |
| priorityDate | 1987-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.